Asterand functional genomics, admet, supply/service news

The board of the tools and tissue-based research services company extended to early next year its deadline to consider the sale of all or part of the business. The extension will allow potential acquirers more time for due diligence. The company extended the time period after a revised cash position showed the company has sufficient cash to fund operations through early 2012. The board's timeline includes a Jan. 5 deadline for submissions and a Feb. 6 formal sales announcement. ...